» Articles » PMID: 16093381

Blocking Caspase Activity Prevents Transsynaptic Neuronal Apoptosis and the Loss of Inhibition in Lamina II of the Dorsal Horn After Peripheral Nerve Injury

Overview
Journal J Neurosci
Specialty Neurology
Date 2005 Aug 12
PMID 16093381
Citations 174
Authors
Affiliations
Soon will be listed here.
Abstract

We show that transsynaptic apoptosis is induced in the superficial dorsal horn (laminas I-III) of the spinal cord by three distinct partial peripheral nerve lesions: spared nerve injury, chronic constriction, and spinal nerve ligation. Ongoing activity in primary afferents of the injured nerve and glutamatergic transmission cause a caspase-dependent degeneration of dorsal horn neurons that is slow in onset and persists for several weeks. Four weeks after spared nerve injury, the cumulative loss of dorsal horn neurons, determined by stereological analysis, is >20%. GABAergic inhibitory interneurons are among the neurons lost, and a marked decrease in inhibitory postsynaptic currents of lamina II neurons coincides with the induction of apoptosis. Blocking apoptosis with the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD) prevents the loss of GABAergic interneurons and the reduction of inhibitory currents. Partial peripheral nerve injury results in pain-like behavioral changes characterized by hypersensitivity to tactile or cold stimuli. Treatment with zVAD, which has no intrinsic analgesic properties, attenuates this neuropathic pain-like syndrome. Preventing nerve injury-induced apoptosis of dorsal horn neurons by blocking caspase activity maintains inhibitory transmission in lamina II and reduces pain hypersensitivity.

Citing Articles

A microfluidic model of the first sensory synapse for analgesic target discovery.

Kimourtzis G, Raouf R Mol Pain. 2024; 20:17448069241293286.

PMID: 39415077 PMC: 11565614. DOI: 10.1177/17448069241293286.


Peripheral and central pathogenesis of postherpetic neuralgia.

Liu Q, Han J, Zhang X Skin Res Technol. 2024; 30(8):e13867.

PMID: 39101621 PMC: 11299165. DOI: 10.1111/srt.13867.


A Narrative Review of the Dorsal Root Ganglia and Spinal Cord Mechanisms of Action of Neuromodulation Therapies in Neuropathic Pain.

da Silva M, Martelossi-Cebinelli G, Yaekashi K, Carvalho T, Borghi S, Casagrande R Brain Sci. 2024; 14(6).

PMID: 38928589 PMC: 11202229. DOI: 10.3390/brainsci14060589.


Exploring the Thalamus as a Target for Neuropathic Pain Management: An Integrative Review.

Pires M, McBenedict B, Ahmed I, Yau R, Fong Y, Goh K Cureus. 2024; 16(5):e60130.

PMID: 38864037 PMC: 11165437. DOI: 10.7759/cureus.60130.


[6]-Shogaol and [6]-Gingerol active ingredients may improve neuropathic pain by suppressing cytokine levels in an experimental model.

Ozdemir F, Akcay G, Ozkinali S, Celik C Turk J Med Sci. 2024; 53(6):1593-1604.

PMID: 38813490 PMC: 10760556. DOI: 10.55730/1300-0144.5728.


References
1.
West M . Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 1999; 22(2):51-61. DOI: 10.1016/s0166-2236(98)01362-9. View

2.
Dirnagl U, Iadecola C, Moskowitz M . Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999; 22(9):391-7. DOI: 10.1016/s0166-2236(99)01401-0. View

3.
Ekert P, Silke J, Vaux D . Caspase inhibitors. Cell Death Differ. 1999; 6(11):1081-6. DOI: 10.1038/sj.cdd.4400594. View

4.
Liu X, Eschenfelder S, Blenk K, Janig W, Habler H . Spontaneous activity of axotomized afferent neurons after L5 spinal nerve injury in rats. Pain. 2000; 84(2-3):309-18. DOI: 10.1016/s0304-3959(99)00211-0. View

5.
Michaelis M, Liu X, Janig W . Axotomized and intact muscle afferents but no skin afferents develop ongoing discharges of dorsal root ganglion origin after peripheral nerve lesion. J Neurosci. 2000; 20(7):2742-8. PMC: 6772259. View